drug
as of 2026-07-01LY03020
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Luye Pharma Group Ltd.
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
4
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
NCT07396870Phase 2Not Yet Recruiting
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
NCT07230652Phase 1Recruiting
A Food Effect Study of LY03020 in Healthy Subjects
NCT07292233Phase 1Active Not Recruiting
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
NCT06556966Phase 1Completed
KOLs & investigators
1
Gang Wang, MDKOL score 7
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here